EUVIMEDEUVIMED entdecken
Crossref

Salvage radiotherapy for locoregional recurrence of esophageal cancer after surgery

Akira Torii iD, Natsuo Tomita iD, Taiki Takaoka iD, Takuhito Kondo, Shintaro Yamamoto, Chikao Sugie, Aiko Nagai, Akifumi Miyakawa, Mayu Kuno, Kaoru Uchiyama, Shinya Otsuka, Yasutaka Ogawa und 8 weitere

Japanese Journal of Clinical Oncology · 2025

DOI: 10.1093/jjco/hyae124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, 2025. Verfasst von Akira Torii und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Salvage Therapy, Neoplasm Recurrence, Local. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

There is no consensus on the optimal treatment for patients with locoregional recurrence of esophageal cancer after surgery. The objective of this study was to investigate the outcomes and prognostic factors associated with salvage radiotherapy in patients with locoregional recurrence of esophageal cancer after surgery.

Methods

We reviewed 80 patients with locoregional recurrence of esophageal cancer after surgery who were treated with radiotherapy. The median dose was 60 Gy, and 29 patients (36%) received elective nodal irradiation. Fifty-three patients (66%) received concurrent chemotherapy (mostly 5-fluorouracil and cisplatin) during radiotherapy. Overall survival, progression-free survival and in-field recurrence rate were assessed.

Results

The median follow-up period was 17 months. Two-year overall survival, progression-free survival and in-field recurrence rate were 50.3%, 23.5% and 41.3%, respectively. On multivariate analysis, a maximum diameter of locoregional recurrence lesions <30 mm was associated with higher overall survival (P = 0.044). Disease-free interval between surgery and locoregional recurrence >14 months was associated with higher PFS (P = 0.003). Late grade 3 toxicities occurred in three patients (3.8%). No grade 4 or higher toxicity was observed.

Conclusions

Salvage radiotherapy demonstrated efficacy in achieving in-field control with acceptable toxicity. However, the high rate of out-of-field metastases led to poor progression-free survival and overall survival, particularly in cases involving large lesions and a short disease-free interval. A prospective study is warranted to establish a treatment strategy, particularly considering the combined use of effective anti-cancer drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsSalvage TherapyNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedAgedAdultRetrospective StudiesEsophagectomyAged, 80 and overFluorouracilPrognosisFollow-Up StudiesChemoradiotherapyCisplatin

Stichwörter der Autor:innen

elective nodal irradiationesophageal cancerlocoregional recurrenceradiotherapysalvage treatment

Substanzen

FluorouracilCisplatin

Autor:innen und Institutionen

  • Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.
  • Department of Radiology, Nagoya Ekisaikai Hospital, 4-66 Syonen-cho, Nakagawa-ku, Nagoya, Aichi 454-8502, Japan.
  • Department of Radiology, Japan Community Health care Organization Chukyo Hospital, 1-1-10 Sanjo, Minami-ku, Nagoya, Aichi 457-8510, Japan.
  • Department of Radiology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi 466-8650, Japan.
  • Department of Radiation Oncology, Nagoya City University East Medical Center, 1-2-23 Wakamizu, Chikusa-ku, Nagoya, Aichi 464-8547, Japan.
  • Department of Radiation Oncology, National Hospital Organization Nagoya Medical Center, 4- 1-1, Sannomaru, Naka-ku, Nagoya, Aichi 460-0001, Japan.

ORCID-Profile: Akira Torii, Natsuo Tomita, Taiki Takaoka

Zitieren

APA

Torii, A., Tomita, N., Takaoka, T., Kondo, T., Yamamoto, S., Sugie, C., Nagai, A., Miyakawa, A., Kuno, M., Uchiyama, K., Otsuka, S., Ogawa, Y., Takano, S., Kita, N., Tanaka, T., Ogawa, R., Kubota, E., Takiguchi, S., Kataoka, H., & Hiwatashi, A. (2025). Salvage radiotherapy for locoregional recurrence of esophageal cancer after surgery. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyae124

Vancouver

Torii A, Tomita N, Takaoka T, Kondo T, Yamamoto S, Sugie C, et al. Salvage radiotherapy for locoregional recurrence of esophageal cancer after surgery. Japanese Journal of Clinical Oncology. 2025. doi:10.1093/jjco/hyae124

BibTeX
@article{Torii2025,
  author = {Torii, Akira and Tomita, Natsuo and Takaoka, Taiki and Kondo, Takuhito and Yamamoto, Shintaro and Sugie, Chikao and Nagai, Aiko and Miyakawa, Akifumi and Kuno, Mayu and Uchiyama, Kaoru and Otsuka, Shinya and Ogawa, Yasutaka and Takano, Seiya and Kita, Nozomi and Tanaka, Tatsuya and Ogawa, Ryo and Kubota, Eiji and Takiguchi, Shuji and Kataoka, Hiromi and Hiwatashi, Akio},
  title = {Salvage radiotherapy for locoregional recurrence of esophageal cancer after surgery},
  journal = {Japanese Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1093/jjco/hyae124}
}
Kostenlos starten →